CheckMate 7DX
03 Dec 2020
CheckMate 7DX
NCT04100018
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
Bristol-Myers Squibb
Cancer Type | Prostate |
---|---|
Trial Type | Treatment |
Phase | Phase III |
Age Range | 18 years and older |
Sex | Male |
Tumour Stream | - |
Cancer Stage | Metastatic or Widespread |
Anticipated Start Date | 2019-12-06 |
Anticipated End Date | 2024-07-06 |
Hospital | Calvary Central Districts Hospital |
---|---|
Clinical Trial Coordinator | Julie Rowe |
julie.rowe@calvarycare.org.au | |
Phone | 08 8239 9536 |
Principal Investigator | Dr Vineet Kwatra |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs